Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$9K Buy
+331
New +$10.2K ﹤0.01% 8938
2014
Q2
Sell
-590
Closed -$18K 10750
2014
Q1
$18K Sell
590
-4,428
-88% -$133K ﹤0.01% 8240
2013
Q4
$143K Buy
5,018
+2,657
+113% +$85.8K ﹤0.01% 5660
2013
Q3
$89K Sell
2,361
-7,085
-75% -$272K ﹤0.01% 6147
2013
Q2
$354K Buy
+9,446
New +$366K ﹤0.01% 4471

Other funds holding RYN

UBS's RYN Position: Q3 2014 in Review

UBS reduced its Rayonier (RYN) stake by 30% in Q3 2014, selling an estimated $2.07M and leaving 157,008 shares worth $4.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2146.

UBS first reported a position in RYN in Q2 2013 and has held it in 6 quarters since. The position peaked at $9.87M in Q2 2013. 401 funds tracked by Wall St. Rank hold RYN as of Q3 2014.

  • UBS held 157,008 shares of Rayonier worth $4.44M as of Q3 2014.
  • UBS sold 67,492 Rayonier shares in Q3 2014, an estimated $2.07M.
  • Rayonier made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2146 holding.
  • UBS first reported a position in Rayonier in Q2 2013 and has held it in 6 quarters since.
  • UBS's Rayonier position peaked at $9.87M in Q2 2013.
  • 401 funds tracked by Wall St. Rank held Rayonier as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.